Featured Research

from universities, journals, and other organizations

Say yes to a clinical trial; it may be good for your health

Date:
November 16, 2009
Source:
European Society of Cardiology
Summary:
A new study finds that heart failure patients willing to take part in clinical trials have a better prognosis than those unwilling to do so.

Patients with chronic heart failure who agree to take part in clinical trials have a better prognosis than those who do not, according to a study reported in the November European Journal of Heart Failure. The finding, say the authors, may even call into question the commonplace ethical requirement of most clinical trials that by choosing not to take part in the study a patient will not be disadvantaged.

The study was a follow-up of 2332 consecutive patients diagnosed with chronic heart failure at Castle Hill Hospital, Hull, UK. At their initial visit to the clinic all were asked if they would be willing to take part in clinical research projects. After a median follow-up of 55.7 months, analysis of the full cohort showed that 792 (34%) had died. However, survival was significantly associated with a willingness to take part in clinical trials, which more than halved the risk of death (hazard ratio 0.33).

The authors note that outcomes for patients with chronic heart failure are generally very poor; epidemiological studies show that around 40% of patients diagnosed with chronic heart failure die within a year of diagnosis.(2) "However," says investigator Dr Andrew Clark from Castle Hill Hospital, "two-year mortality rate in recent trials of chronic heart failure trials has been in the order of 20%. And even in studies of very sick patients, mortality has only been 30%. So we wanted to see if taking part in a clinical trial was associated with a beneficial outcome."

Additionally, to explore the effect on survival of actually entering a clinical trial (rather than simply indicating a willingness to take part) survival after the first year was compared between "willing" patients who were recruited to a trial and willing patients who were not.

The single most powerful predictor of all-cause mortality in the whole cohort (p<0.0001) -- from a multivariate model of 19 clinical and social variables -- was willingness to take part in a trial, with a "protective" hazard ratio of 0.33 (95% CI, 0.26-0.40). This was a predictor of good outcome independent of age, severity of left ventricular dysfunction, renal function, sodium levels, drug use, and co-morbidities. Indeed, other likely protective variables, such as good mobility (HR 0.91) or appropriate medication were not significant predictors in the multivariate model.

However, results from the second analysis showed that actually being recruited into a clinical trial was not predictive of outcome. "We found no appreciable difference in survival between those who are actually recruited to an interventional trial within the first year and those who were not," says Dr Clark.

The investigators are unable to offer an obvious explanation for the findings, finding no systematic difference between their two study groups. They do, however, suggest that "being prepared to take part in a trial is a marker for better compliance with, and acceptance of, treatment." They add that "patients' attitudes to their illness and its treatment is an important aspect of their care".

The study also highlighted the difference between real-life heart failure patients and those recruited to clinical trials -- and this, say the investigators, may explain the difference seen in survival rates between the populations in clinical trials and those in everyday life. "Our study contributes to the perception that heart failure trials can be unrepresentative of real life," says Dr Clark, "particularly as study designs often deliberately exclude patients with an inherently poor prognosis, such as those with anaemia or impaired renal function. Both these co-morbidities are common in real-life populations."


Story Source:

The above story is based on materials provided by European Society of Cardiology. Note: Materials may be edited for content and length.


Journal References:

  1. Clark AL, Lammiman MJ, Goode, K, Cleland JGF. Is taking part in clinical trials good for your health? A cohort study. European Journal of Heart Failure, 2009; 11 (11): 1078 DOI: 10.1093/eurjhf/hfp133
  2. Cowie MR, Woods DA, Coats AJ, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart, 2000; 83 (5): 505 DOI: 10.1136/heart.83.5.505
  3. Wang O, Krumholz HM. Clinical trial participation: are we studying the patients we are trying to treat? European Journal of Heart Failure, 2009; 11 (11): 1021 DOI: 10.1093/eurjhf/hfp137

Cite This Page:

European Society of Cardiology. "Say yes to a clinical trial; it may be good for your health." ScienceDaily. ScienceDaily, 16 November 2009. <www.sciencedaily.com/releases/2009/10/091030095515.htm>.
European Society of Cardiology. (2009, November 16). Say yes to a clinical trial; it may be good for your health. ScienceDaily. Retrieved April 18, 2014 from www.sciencedaily.com/releases/2009/10/091030095515.htm
European Society of Cardiology. "Say yes to a clinical trial; it may be good for your health." ScienceDaily. www.sciencedaily.com/releases/2009/10/091030095515.htm (accessed April 18, 2014).

Share This



More Health & Medicine News

Friday, April 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

'Holy Grail' Of Weight Loss? New Find Could Be It

'Holy Grail' Of Weight Loss? New Find Could Be It

Newsy (Apr. 18, 2014) In a potential breakthrough for future obesity treatments, scientists have used MRI scans to pinpoint brown fat in a living adult for the first time. Video provided by Newsy
Powered by NewsLook.com
Scientists Create Stem Cells From Adult Skin Cells

Scientists Create Stem Cells From Adult Skin Cells

Newsy (Apr. 17, 2014) The breakthrough could mean a cure for some serious diseases and even the possibility of human cloning, but it's all still a way off. Video provided by Newsy
Powered by NewsLook.com
Obama: 8 Million Healthcare Signups

Obama: 8 Million Healthcare Signups

AP (Apr. 17, 2014) President Barack Obama gave a briefing Thursday announcing 8 million people have signed up under the Affordable Care Act. He blasted continued Republican efforts to repeal the law. (April 17) Video provided by AP
Powered by NewsLook.com
Is Apathy A Sign Of A Shrinking Brain?

Is Apathy A Sign Of A Shrinking Brain?

Newsy (Apr. 17, 2014) A recent study links apathetic feelings to a smaller brain. Researchers say the results indicate a need for apathy screening for at-risk seniors. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins